Key points are not available for this paper at this time.
Of 274,000 deaths due to cervical cancer each year, more than 80% occur in developing countries. Drs. Jan Agosti and Sue Goldie suggest that there is sufficient evidence to support global policy recommendations for the introduction of HPV vaccine.
Agosti et al. (Wed,) studied this question.